Global Saliva-based Screening Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Saliva-based Screening
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Saliva-based Screening by Type
  • 1.3.1 Overview: Global Saliva-based Screening Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Saliva-based Screening Consumption Value Market Share by Type in 2022
  • 1.3.3 Direct Sample to PCR
  • 1.3.4 RT-qPCR
  • 1.3.5 Lateral Flow Assays
• 1.4 Global Saliva-based Screening Market by Application
  • 1.4.1 Overview: Global Saliva-based Screening Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Diagnostic Laboratories
  • 1.4.3 Hospitals & Clinics
  • 1.4.4 Others
• 1.5 Global Saliva-based Screening Market Size & Forecast
• 1.6 Global Saliva-based Screening Market Size and Forecast by Region
  • 1.6.1 Global Saliva-based Screening Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Saliva-based Screening Market Size by Region, (2018-2029)
  • 1.6.3 North America Saliva-based Screening Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Saliva-based Screening Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Saliva-based Screening Market Size and Prospect (2018-2029)
  • 1.6.6 South America Saliva-based Screening Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Saliva-based Screening Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Thermo Fisher scientific
  • 2.1.1 Thermo Fisher scientific Details
  • 2.1.2 Thermo Fisher scientific Major Business
  • 2.1.3 Thermo Fisher scientific Saliva-based Screening Product and Solutions
  • 2.1.4 Thermo Fisher scientific Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Thermo Fisher scientific Recent Developments and Future Plans
• 2.2 Qiagen
  • 2.2.1 Qiagen Details
  • 2.2.2 Qiagen Major Business
  • 2.2.3 Qiagen Saliva-based Screening Product and Solutions
  • 2.2.4 Qiagen Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Qiagen Recent Developments and Future Plans
• 2.3 Hologic
  • 2.3.1 Hologic Details
  • 2.3.2 Hologic Major Business
  • 2.3.3 Hologic Saliva-based Screening Product and Solutions
  • 2.3.4 Hologic Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Hologic Recent Developments and Future Plans
• 2.4 Takara Bio Inc
  • 2.4.1 Takara Bio Inc Details
  • 2.4.2 Takara Bio Inc Major Business
  • 2.4.3 Takara Bio Inc Saliva-based Screening Product and Solutions
  • 2.4.4 Takara Bio Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Takara Bio Inc Recent Developments and Future Plans
• 2.5 Arcis Biotechnology Limited
  • 2.5.1 Arcis Biotechnology Limited Details
  • 2.5.2 Arcis Biotechnology Limited Major Business
  • 2.5.3 Arcis Biotechnology Limited Saliva-based Screening Product and Solutions
  • 2.5.4 Arcis Biotechnology Limited Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Arcis Biotechnology Limited Recent Developments and Future Plans
• 2.6 GeneProof
  • 2.6.1 GeneProof Details
  • 2.6.2 GeneProof Major Business
  • 2.6.3 GeneProof Saliva-based Screening Product and Solutions
  • 2.6.4 GeneProof Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 GeneProof Recent Developments and Future Plans
• 2.7 Abacus ALS
  • 2.7.1 Abacus ALS Details
  • 2.7.2 Abacus ALS Major Business
  • 2.7.3 Abacus ALS Saliva-based Screening Product and Solutions
  • 2.7.4 Abacus ALS Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 Abacus ALS Recent Developments and Future Plans
• 2.8 Chai Inc.
  • 2.8.1 Chai Inc. Details
  • 2.8.2 Chai Inc. Major Business
  • 2.8.3 Chai Inc. Saliva-based Screening Product and Solutions
  • 2.8.4 Chai Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Chai Inc. Recent Developments and Future Plans
• 2.9 Kolplast Group
  • 2.9.1 Kolplast Group Details
  • 2.9.2 Kolplast Group Major Business
  • 2.9.3 Kolplast Group Saliva-based Screening Product and Solutions
  • 2.9.4 Kolplast Group Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Kolplast Group Recent Developments and Future Plans
• 2.10 Lucence Health INc
  • 2.10.1 Lucence Health INc Details
  • 2.10.2 Lucence Health INc Major Business
  • 2.10.3 Lucence Health INc Saliva-based Screening Product and Solutions
  • 2.10.4 Lucence Health INc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Lucence Health INc Recent Developments and Future Plans
• 2.11 Vitagene
  • 2.11.1 Vitagene Details
  • 2.11.2 Vitagene Major Business
  • 2.11.3 Vitagene Saliva-based Screening Product and Solutions
  • 2.11.4 Vitagene Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Vitagene Recent Developments and Future Plans
• 2.12 Therma Bright Inc
  • 2.12.1 Therma Bright Inc Details
  • 2.12.2 Therma Bright Inc Major Business
  • 2.12.3 Therma Bright Inc Saliva-based Screening Product and Solutions
  • 2.12.4 Therma Bright Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 Therma Bright Inc Recent Developments and Future Plans
• 2.13 ACON Laboratories, Inc
  • 2.13.1 ACON Laboratories, Inc Details
  • 2.13.2 ACON Laboratories, Inc Major Business
  • 2.13.3 ACON Laboratories, Inc Saliva-based Screening Product and Solutions
  • 2.13.4 ACON Laboratories, Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.13.5 ACON Laboratories, Inc Recent Developments and Future Plans
• 2.14 TODA PHARMA
  • 2.14.1 TODA PHARMA Details
  • 2.14.2 TODA PHARMA Major Business
  • 2.14.3 TODA PHARMA Saliva-based Screening Product and Solutions
  • 2.14.4 TODA PHARMA Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.14.5 TODA PHARMA Recent Developments and Future Plans
• 2.15 Norgen Biotek Corp.
  • 2.15.1 Norgen Biotek Corp. Details
  • 2.15.2 Norgen Biotek Corp. Major Business
  • 2.15.3 Norgen Biotek Corp. Saliva-based Screening Product and Solutions
  • 2.15.4 Norgen Biotek Corp. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.15.5 Norgen Biotek Corp. Recent Developments and Future Plans
• 2.16 Assure Tech. (Hangzhou) Co., Ltd
  • 2.16.1 Assure Tech. (Hangzhou) Co., Ltd Details
  • 2.16.2 Assure Tech. (Hangzhou) Co., Ltd Major Business
  • 2.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product and Solutions
  • 2.16.4 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Developments and Future Plans
• 2.17 Beijing Hotgen Biotech Co., Ltd
  • 2.17.1 Beijing Hotgen Biotech Co., Ltd Details
  • 2.17.2 Beijing Hotgen Biotech Co., Ltd Major Business
  • 2.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product and Solutions
  • 2.17.4 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.17.5 Beijing Hotgen Biotech Co., Ltd Recent Developments and Future Plans
• 2.18 Nantong Diagnos Biotechnology Co., Ltd
  • 2.18.1 Nantong Diagnos Biotechnology Co., Ltd Details
  • 2.18.2 Nantong Diagnos Biotechnology Co., Ltd Major Business
  • 2.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product and Solutions
  • 2.18.4 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Developments and Future Plans
• 2.19 NeuMoDx Molecular, Inc.
  • 2.19.1 NeuMoDx Molecular, Inc. Details
  • 2.19.2 NeuMoDx Molecular, Inc. Major Business
  • 2.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Product and Solutions
  • 2.19.4 NeuMoDx Molecular, Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.19.5 NeuMoDx Molecular, Inc. Recent Developments and Future Plans
• 2.20 KYODO INTERNATIONAL INC.
  • 2.20.1 KYODO INTERNATIONAL INC. Details
  • 2.20.2 KYODO INTERNATIONAL INC. Major Business
  • 2.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Product and Solutions
  • 2.20.4 KYODO INTERNATIONAL INC. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.20.5 KYODO INTERNATIONAL INC. Recent Developments and Future Plans
• 2.21 Canvax
  • 2.21.1 Canvax Details
  • 2.21.2 Canvax Major Business
  • 2.21.3 Canvax Saliva-based Screening Product and Solutions
  • 2.21.4 Canvax Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.21.5 Canvax Recent Developments and Future Plans
• 2.22 Zymo Research Corporation.
  • 2.22.1 Zymo Research Corporation. Details
  • 2.22.2 Zymo Research Corporation. Major Business
  • 2.22.3 Zymo Research Corporation. Saliva-based Screening Product and Solutions
  • 2.22.4 Zymo Research Corporation. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.22.5 Zymo Research Corporation. Recent Developments and Future Plans
• 2.23 Salimetrics
  • 2.23.1 Salimetrics Details
  • 2.23.2 Salimetrics Major Business
  • 2.23.3 Salimetrics Saliva-based Screening Product and Solutions
  • 2.23.4 Salimetrics Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.23.5 Salimetrics Recent Developments and Future Plans
• 2.24 NEST Scientific USA
  • 2.24.1 NEST Scientific USA Details
  • 2.24.2 NEST Scientific USA Major Business
  • 2.24.3 NEST Scientific USA Saliva-based Screening Product and Solutions
  • 2.24.4 NEST Scientific USA Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.24.5 NEST Scientific USA Recent Developments and Future Plans
• 2.25 Miraclean Technology Co. Ltd
  • 2.25.1 Miraclean Technology Co. Ltd Details
  • 2.25.2 Miraclean Technology Co. Ltd Major Business
  • 2.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Product and Solutions
  • 2.25.4 Miraclean Technology Co. Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.25.5 Miraclean Technology Co. Ltd Recent Developments and Future Plans
• 2.26 Mawi DNA Technologies
  • 2.26.1 Mawi DNA Technologies Details
  • 2.26.2 Mawi DNA Technologies Major Business
  • 2.26.3 Mawi DNA Technologies Saliva-based Screening Product and Solutions
  • 2.26.4 Mawi DNA Technologies Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.26.5 Mawi DNA Technologies Recent Developments and Future Plans
• 2.27 Cell Projects Ltd.
  • 2.27.1 Cell Projects Ltd. Details
  • 2.27.2 Cell Projects Ltd. Major Business
  • 2.27.3 Cell Projects Ltd. Saliva-based Screening Product and Solutions
  • 2.27.4 Cell Projects Ltd. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.27.5 Cell Projects Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Saliva-based Screening Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Saliva-based Screening by Company Revenue
  • 3.2.2 Top 3 Saliva-based Screening Players Market Share in 2022
  • 3.2.3 Top 6 Saliva-based Screening Players Market Share in 2022
• 3.3 Saliva-based Screening Market: Overall Company Footprint Analysis
  • 3.3.1 Saliva-based Screening Market: Region Footprint
  • 3.3.2 Saliva-based Screening Market: Company Product Type Footprint
  • 3.3.3 Saliva-based Screening Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Saliva-based Screening Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Saliva-based Screening Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Saliva-based Screening Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Saliva-based Screening Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Saliva-based Screening Consumption Value by Type (2018-2029)
• 6.2 North America Saliva-based Screening Consumption Value by Application (2018-2029)
• 6.3 North America Saliva-based Screening Market Size by Country
  • 6.3.1 North America Saliva-based Screening Consumption Value by Country (2018-2029)
  • 6.3.2 United States Saliva-based Screening Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Saliva-based Screening Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Saliva-based Screening Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Saliva-based Screening Consumption Value by Type (2018-2029)
• 7.2 Europe Saliva-based Screening Consumption Value by Application (2018-2029)
• 7.3 Europe Saliva-based Screening Market Size by Country
  • 7.3.1 Europe Saliva-based Screening Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Saliva-based Screening Market Size and Forecast (2018-2029)
  • 7.3.3 France Saliva-based Screening Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Saliva-based Screening Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Saliva-based Screening Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Saliva-based Screening Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Saliva-based Screening Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Saliva-based Screening Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Saliva-based Screening Market Size by Region
  • 8.3.1 Asia-Pacific Saliva-based Screening Consumption Value by Region (2018-2029)
  • 8.3.2 China Saliva-based Screening Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Saliva-based Screening Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Saliva-based Screening Market Size and Forecast (2018-2029)
  • 8.3.5 India Saliva-based Screening Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Saliva-based Screening Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Saliva-based Screening Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Saliva-based Screening Consumption Value by Type (2018-2029)
• 9.2 South America Saliva-based Screening Consumption Value by Application (2018-2029)
• 9.3 South America Saliva-based Screening Market Size by Country
  • 9.3.1 South America Saliva-based Screening Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Saliva-based Screening Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Saliva-based Screening Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Saliva-based Screening Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Saliva-based Screening Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Saliva-based Screening Market Size by Country
  • 10.3.1 Middle East & Africa Saliva-based Screening Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Saliva-based Screening Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Saliva-based Screening Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Saliva-based Screening Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Saliva-based Screening Market Drivers
• 11.2 Saliva-based Screening Market Restraints
• 11.3 Saliva-based Screening Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Saliva-based Screening Industry Chain
• 12.2 Saliva-based Screening Upstream Analysis
• 12.3 Saliva-based Screening Midstream Analysis
• 12.4 Saliva-based Screening Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source